Kiromic Tangible Assets Book Value per Share from 2010 to 2024
| KRBPDelisted Stock | USD 1.45 0.00 0.00% |
Check Kiromic BiopharmaInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiromic main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Kiromic financial statements analysis is a perfect complement when working with Kiromic BiopharmaInc Valuation or Volatility modules.
Kiromic |
About Kiromic BiopharmaInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Kiromic BiopharmaInc income statement, its balance sheet, and the statement of cash flows. Kiromic BiopharmaInc investors use historical funamental indicators, such as Kiromic BiopharmaInc's Tangible Assets Book Value per Share, to determine how well the company is positioned to perform in the future. Although Kiromic BiopharmaInc investors may use each financial statement separately, they are all related. The changes in Kiromic BiopharmaInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kiromic BiopharmaInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Kiromic BiopharmaInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Kiromic BiopharmaInc. Please read more on our technical analysis and fundamental analysis pages.
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. Kiromic Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kiromic BiopharmaInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kiromic BiopharmaInc's short interest history, or implied volatility extrapolated from Kiromic BiopharmaInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Kiromic BiopharmaInc information on this page should be used as a complementary analysis to other Kiromic BiopharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic BiopharmaInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic BiopharmaInc's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |